STOCK TITAN

Xos (NASDAQ: XOS) raises $6.0M in registered direct stock sale

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

Xos, Inc. entered into securities purchase and placement agency agreements for a registered direct offering of 1,090,910 shares of common stock at $5.50 per share. The company closed the transaction shortly after signing.

The offering generated approximately $6.0 million in gross proceeds before fees and expenses. Roth Capital Partners, LLC acted as exclusive placement agent and will receive a 6.5% cash fee on gross proceeds plus reimbursement of up to $75,000 of expenses.

Positive

  • None.

Negative

  • None.

Insights

Xos raises about $6.0M in a small registered stock sale.

Xos, Inc. completed a registered direct offering of 1,090,910 common shares at $5.50 per share, generating gross proceeds of roughly $6.0 million. The sale used the company’s existing shelf registration and a prospectus supplement filed on June 5, 2026.

Roth Capital Partners, LLC served as exclusive placement agent, earning a 6.5% cash fee on gross proceeds and expense reimbursement up to $75,000. Net cash to Xos will be lower than the gross amount after these costs, but specific net proceeds and uses are not detailed in this excerpt.

The transaction adds primary equity capital to the balance sheet rather than refinancing debt. Future filings may provide more context on how Xos applies these proceeds within its business.

Item 1.01 Entry into a Material Definitive Agreement Business
The company signed a significant contract such as a merger agreement, credit facility, or major partnership.
Item 9.01 Financial Statements and Exhibits Exhibits
Financial statements, pro forma financial information, and exhibit attachments filed with this report.
Shares sold 1,090,910 shares Registered direct offering of common stock
Offering price $5.50 per share Purchase price for common stock in offering
Gross proceeds $6.0 million Aggregate gross proceeds from offering
Placement fee rate 6.5% of gross proceeds Cash fee payable to Roth Capital Partners
Expense reimbursement cap up to $75,000 Reimbursable expenses for placement agent
Warrant exercise price $345.00 per share Every thirty warrants exercisable for one share
registered direct offering financial
"exclusive placement agent in connection with a registered direct offering of 1,090,910 shares"
A registered direct offering is a way for a company to sell new shares of its stock directly to select investors with regulatory approval. This method allows the company to raise funds quickly and efficiently without needing a public auction, similar to offering exclusive access to a limited number of buyers. For investors, it often provides an opportunity to purchase shares at a favorable price, while giving the company immediate access to capital.
Securities Purchase Agreement financial
"entered into (i) a Securities Purchase Agreement (the “Securities Purchase Agreement”) with certain institutional investors"
A securities purchase agreement is a written contract between a buyer and a seller outlining the terms for buying or selling financial assets such as stocks or bonds. It specifies details like the price, quantity, and conditions of the transaction, similar to a shopping list with agreed-upon terms. For investors, it provides clarity and legal protection when transferring ownership of these financial instruments.
Placement Agency Agreement financial
"a Placement Agency Agreement (the “Placement Agency Agreement”) with Roth Capital Partners, LLC"
shelf registration statement on Form S-3 regulatory
"under the Company’s effective shelf registration statement on Form S-3 (File No. 333-272284)"
A shelf registration statement on Form S-3 is a pre-approved filing with the Securities and Exchange Commission that lets an eligible public company register securities in advance and sell them later in one or more offerings without repeating the full registration process. Think of it like a pre-approved funding line: it gives management the flexibility to raise capital quickly when market conditions are right, a move that can affect share supply, dilution and investor returns, so investors monitor it as a signal of potential financing activity.
prospectus supplement regulatory
"a prospectus supplement filed with the SEC pursuant to Rule 424(b) on June 5, 2026"
A prospectus supplement is an additional document provided alongside a company's main offering details, offering updated or extra information about a specific financial product being sold. It helps investors understand the latest terms, risks, and details of the investment, similar to how an update or revision clarifies or expands on original instructions, ensuring they have current and complete information before making a decision.
emerging growth company regulatory
"Emerging growth company Item 1.01 Entry into a Material Definitive Agreement."
An emerging growth company is a recently public or smaller public firm that qualifies for temporary, lighter regulatory and disclosure rules to reduce the cost and effort of being public. For investors, it means the company may provide less historical financial detail and face fewer reporting requirements than larger firms, so it can grow more quickly but also carries higher uncertainty—like buying a promising early-stage product with fewer user reviews.
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
false 0001819493 0001819493 2026-06-04 2026-06-04 0001819493 XOSWW:CommonStockParValue0.0001PerShareMember 2026-06-04 2026-06-04 0001819493 XOSWW:WarrantsEveryThirtyWarrantsExercisableForOneShareOfCommonStockAtExercisePriceOf345.00PerShareMember 2026-06-04 2026-06-04 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

 

Date of Report (Date of earliest event reported): June 4, 2026

 

XOS, INC.

(Exact Name of Registrant as Specified in Its Charter)

 

Delaware   001-39598   98-1550505
(State or Other Jurisdiction of
Incorporation or Organization)
  (Commission File Number)   (I.R.S. Employer
Identification No.)

 

3559 Tyburn Street,
Los Angeles, California
  90065
(Address of Principal Executive Offices)   (Zip Code)

 

(818) 316-1890

(Registrant’s telephone number, including area code)

 

N/A

(Former Name or Former Address, if Changed Since Last Report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of Each Class   Trading
Symbol(s)
  Name of Each Exchange on
Which Registered
Common Stock, par value $0.0001 per share   XOS   Nasdaq Capital Market
Warrants, every thirty warrants exercisable for one share of Common Stock at an exercise price of $345.00 per share   XOSWW   Nasdaq Capital Market

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the Securities Exchange Act of 1934. Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

 

 

 

Item 1.01 Entry into a Material Definitive Agreement.

 

On June 4, 2026, Xos, Inc. (the “Company”) entered into (i) a Securities Purchase Agreement (the “Securities Purchase Agreement”) with certain institutional investors (the “Purchasers”) and (ii) a Placement Agency Agreement (the “Placement Agency Agreement”) with Roth Capital Partners, LLC (“Roth”), pursuant to which Roth acted as the Company’s exclusive placement agent in connection with a registered direct offering of 1,090,910 shares of the Company’s common stock, par value $0.0001 per share (the “Shares”), at a purchase price of $5.50 per share. On June 5, 2026, the Company completed the sale of the Shares pursuant to the Securities Purchase Agreement. The aggregate gross proceeds to the Company from the offering were approximately $6.0 million, before deducting placement agent fees and other offering expenses.

 

Pursuant to the Securities Purchase Agreement, the Shares were offered and sold to the Purchasers under the Company’s effective shelf registration statement on Form S-3 (File No. 333-272284), which was declared effective by the Securities and Exchange Commission (the “SEC”) on June 8, 2023, and a prospectus supplement filed with the SEC pursuant to Rule 424(b) on June 5, 2026.

 

The Securities Purchase Agreement contains customary representations, warranties and agreements of the Company and the Purchasers and customary closing conditions. The representations, warranties and covenants contained in the Securities Purchase Agreement were made solely for the benefit of the parties thereto and may be subject to limitations agreed upon by the contracting parties. In addition, such representations, warranties and covenants (i) are intended as a way of allocating risk between the parties and not as statements of fact and (ii) may apply standards of materiality in a way that is different from what may be viewed as material by investors. Accordingly, the Securities Purchase Agreement is filed with this Current Report on Form 8-K only to provide investors with information regarding its terms and not to provide investors with any other factual information regarding the Company. Investors should not rely on the representations, warranties and covenants or any descriptions thereof as characterizations of the actual state of facts or condition of the Company or any of the other parties thereto.

 

Pursuant to the Placement Agency Agreement, the Company agreed to pay Roth a cash fee equal to 6.5% of the aggregate gross proceeds received by the Company in the offering and to reimburse certain expenses of Roth in an aggregate amount of up to $75,000. The Placement Agency Agreement contains customary representations, warranties and indemnification obligations of the Company.

 

The foregoing descriptions of the Placement Agency Agreement and the Securities Purchase Agreement do not purport to be complete and are qualified in their entirety by reference to the full text of the Placement Agency Agreement and the Securities Purchase Agreement, copies of which are filed as Exhibits 1.1 and 10.1, respectively, to this Current Report on Form 8-K and are incorporated herein by reference.

 

A copy of the opinion of Proskauer Rose LLP relating to the legality of the Shares is filed as Exhibit 5.1 to this Current Report. 

 

Item 9.01 Financial Statements and Exhibits.

 

(d) Exhibits

 

Exhibit
Number
  Description
1.1   Placement Agency Agreement, dated June 4, 2026, by and among Xos, Inc. and Roth Capital Partners, LLC
5.1   Opinion of Proskauer Rose LLP
10.1   Securities Purchase Agreement, dated June 4, 2026, by and among Xos, Inc. and certain investors
23.1   Consent of Proskauer Rose LLP (included in Exhibit 5.1 hereto)
104   Cover Page Interactive Data File (formatted in Inline XBRL in Exhibit 101)

 

1

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  XOS, INC.
  (Registrant)
     
  By: /s/ Liana Pogosyan
Date: June 5, 2026   Liana Pogosyan
    Chief Financial Officer

 

2

FAQ

What did Xos (XOS) announce in this 8-K filing?

Xos disclosed a registered direct offering of 1,090,910 common shares at $5.50 per share. The transaction generated approximately $6.0 million in gross proceeds, completed under its existing shelf registration and a new prospectus supplement.

How much capital did Xos (XOS) raise and on what terms?

Xos raised about $6.0 million in gross proceeds by selling 1,090,910 common shares at $5.50 each. The shares were sold in a registered direct offering to institutional investors under an effective Form S-3 shelf registration statement.

Who acted as placement agent for the Xos (XOS) equity offering?

Roth Capital Partners, LLC served as exclusive placement agent for the Xos offering. Under a placement agency agreement, Roth earns a 6.5% cash fee on gross proceeds and can be reimbursed up to $75,000 for expenses related to the transaction.

What fees will Xos (XOS) pay in connection with this stock sale?

Xos agreed to pay Roth Capital Partners, LLC a cash fee equal to 6.5% of aggregate gross proceeds. The company will also reimburse certain placement agent expenses in an amount up to $75,000, reducing the net cash received from the transaction.

Under what registration did Xos (XOS) sell these new shares?

The shares were sold under Xos’s effective shelf registration statement on Form S-3, File No. 333-272284. A related prospectus supplement was filed with the SEC under Rule 424(b) on June 5, 2026 to cover this specific offering.

What agreements did Xos (XOS) enter into for this offering?

Xos entered a Securities Purchase Agreement with institutional investors and a Placement Agency Agreement with Roth Capital Partners, LLC. These agreements contain customary representations, warranties, covenants, closing conditions, and indemnification typical for a registered direct equity offering.

Filing Exhibits & Attachments

7 documents